3min chapter

The Long Run with Luke Timmerman cover image

Ep123: Tariq Kassum on Single-Cell Analysis for Drug Discovery

The Long Run with Luke Timmerman

CHAPTER

Bringing More Controllability to Cell Therapies

The all or nothing nature of the risk in a biotech company like that concentrates the mind. A project about controllable Carti transgens, you could very easily imagine somebody in a pharma company working on something like that. For this kind of innovation, because those problems aren't existential for the people at the pharma company, it's easier to move on to something else.

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode